Subsequent studies have revealed that heterozygous TREM2 mutations have been implicated as risk factors for multiple neurodegenerative diseases, including AD, frontotemporal dementia (FTD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Here, TREM2 is linked to neurodegenerative disease.